ENGN enGene Holdings Inc.
Healthcare$1.76+7.32%ClosedMarket Cap: $90.1M
As of 2026-05-26
Analyst Consensus
Consensus
Hold
Target (Consensus)
$9.57
Target (Median)
$4.00
Target Range
$2.00 - $28.00
Upside from current price: 443.8%
Rating Distribution
2 Strong Buy7 Buy8 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-14 | UBS | maintain | Neutral | Neutral |
| 2026-05-08 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-05-08 | Wells Fargo | downgrade | Equal Weight | Overweight |
| 2026-05-08 | Guggenheim | downgrade | Neutral | Buy |
| 2026-05-08 | Citizens | downgrade | Market Perform | Market Outperform |
| 2026-05-08 | Piper Sandler | downgrade | Neutral | Overweight |
| 2026-03-11 | Oppenheimer | maintain | Outperform | Outperform |
| 2026-03-09 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-11-12 | Morgan Stanley | maintain | Overweight | Overweight |
| 2025-11-12 | UBS | maintain | Neutral | Neutral |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Sun Oct 31 | $-1.96 | $7.6M | 7 |
| Tue Oct 31 | $-1.54 | $53.3M | 3 |
| Wed Oct 31 | $-1.00 | $131.4M | 4 |
| Thu Oct 31 | $-0.56 | $216.4M | 2 |